Mark Pruzanski
Directeur/Bestuurslid bij EQUILLIUM, INC.
Vermogen: 35 699 $ op 31-05-2024
Actieve functies van Mark Pruzanski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EQUILLIUM, INC. | Directeur/Bestuurslid | 01-09-2018 | - |
| Independent Dir/Board Member | 01-09-2018 | - | |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Algemeen Directeur | 01-04-2022 | - |
| Voorzitter | 01-04-2022 | - | |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | Directeur/Bestuurslid | 19-08-2015 | - |
| Foundation for the Defense of Democracies | Directeur/Bestuurslid | - | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Bestuurslid | - | - |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - | - |
Loopbaan van Mark Pruzanski
Eerdere bekende functies van Mark Pruzanski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 04-09-2002 | 08-11-2023 |
| Algemeen Directeur | 04-09-2002 | 01-01-2021 | |
| Oprichter | 04-09-2002 | 08-11-2023 | |
| President | 04-09-2002 | 01-01-2021 | |
| EVELO BIOSCIENCES, INC. | Directeur/Bestuurslid | - | 01-01-2017 |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Oprichter | 01-09-1999 | 01-07-2002 |
| Corporate Officer/Principal | 01-09-1999 | 01-07-2002 | |
| ░░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Opleiding van Mark Pruzanski
| McGill University | Undergraduate Degree |
| McMaster University | Doctorate Degree |
| Paul H. Nitze School of Advanced International Studies (IT) | Graduate Degree |
| Johns Hopkins University School of Advanced International | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 13 |
| Canada | 4 |
| Italië | 2 |
Operationeel
| Director/Board Member | 8 |
| Chief Executive Officer | 3 |
| Founder | 3 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 5 |
| Commercial Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| Bedrijven in privébezit | 10 |
|---|---|
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Finance |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
| Foundation for the Defense of Democracies | |
gIcare Pharma, Inc.
 gIcare Pharma, Inc. Pharmaceuticals: MajorHealth Technology gIcare Pharma, Inc. develops gastrointestinal drugs. It develops orally-administered drug GIC-1001 which provides colonic analgesia. The company was founded by Patrick Colin and Maxime Ranger in 2011 and is headquartered in Montreal, Canada. | Health Technology |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | Commercial Services |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Health Technology |
| MedicinePlanet, Inc. |
- Beurs
- Insiders
- Mark Pruzanski
- Ervaring
